Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Assessing the risk of second primary lung cancer in women after previous breast cancer.

About this Publication
Title
Assessing the risk of second primary lung cancer in women after previous breast cancer.
Pubmed ID
40374891 (View this publication on the PubMed website)
Digital Object Identifier
Publication
BJC Rep. 2025 May 15; Volume 3 (Issue 1): Pages 33
Authors
Huang Y, Lin JJ, Wisnivesky JP, Kong CY, Sigel K
Affiliations
  • Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. yuanhui.huang@icahn.mssm.edu.
  • Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract

BACKGROUND: Breast cancer (BC) survivors may be at increased risk of developing second cancers compared to those without BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. This study aimed to evaluate the association between BC and the subsequent incidence of LC.

METHODS: Women aged 55-74 were identified from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. The risk of incident LC was compared by BC status using a multivariable Cox regression model with BC and smoking exposures incorporated as time-updated variables.

RESULTS: 75,951 females from the PLCO trial were identified, with 5808 diagnosed with BC after enrollment. The unadjusted incidence rate (IR) of the second LC was significantly higher among BC survivors than non-BC participants (231 vs. 172 per 100,000 person-years). The adjusted hazard ratio (HR) for the second primary LC associated with BC diagnosis was 1.24 (95% CI: 1.03-1.49).

CONCLUSIONS: BC diagnosis was an independent risk factor for the development of second primary LC. Consequently, BC survivors may derive benefits from enhanced LC screening interventions.

Related CDAS Studies
Related CDAS Projects